Xconomy | Boston - Business + Technology in the Exponential Economy

A Lawsuit for Biogen, A Suitor for Millennium, The Suits Who Made Their Own Fate, & More Life Sciences News
Omeros, Developer of Knee-Surgery Enhancer, Raises $20 Million in Debt Financing
Aileron Therapeutics, Inc. Receives $10,000,000 New Funding Round
Aileron Therapeutics, Inc. Obtains $10,000,000 New Financing Round
Aurora, Draper Labs, and BAE Team, IBM’s Merger Machine Steams, Lonelygirl15 Beams, & More Deals News

Aileron Raises $10 Million

Cambridge-based biopharmaceutical company Aileron Therapeutics, which is developing peptide drugs for the treatment of cancer and other diseases, has raised $10 million in a private placement of preferred stock, the company announced today. Apple Tree Partners and the Novartis Venture Fund led the round.

Comments | Permalink |